201 related articles for article (PubMed ID: 22158723)
1. An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis.
Prajapati VK; Awasthi K; Yadav TP; Rai M; Srivastava ON; Sundar S
J Infect Dis; 2012 Jan; 205(2):333-6. PubMed ID: 22158723
[TBL] [Abstract][Full Text] [Related]
2. Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes.
Prajapati VK; Awasthi K; Gautam S; Yadav TP; Rai M; Srivastava ON; Sundar S
J Antimicrob Chemother; 2011 Apr; 66(4):874-9. PubMed ID: 21393222
[TBL] [Abstract][Full Text] [Related]
3. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.
Thakur CP; Dedet JP; Narain S; Pratlong F
Trans R Soc Trop Med Hyg; 2001; 95(2):187-9. PubMed ID: 11355558
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.
Sánchez-Brunete JA; Dea MA; Rama S; Bolás F; Alunda JM; Raposo R; Méndez MT; Torrado-Santiago S; Torrado JJ
Antimicrob Agents Chemother; 2004 Sep; 48(9):3246-52. PubMed ID: 15328080
[TBL] [Abstract][Full Text] [Related]
5. Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies.
Mudavath SL; Talat M; Rai M; Srivastava ON; Sundar S
Drug Des Devel Ther; 2014; 8():1235-47. PubMed ID: 25214767
[TBL] [Abstract][Full Text] [Related]
6. Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations.
Loiseau PM; Imbertie L; Bories C; Betbeder D; De Miguel I
Antimicrob Agents Chemother; 2002 May; 46(5):1597-601. PubMed ID: 11959611
[TBL] [Abstract][Full Text] [Related]
7. Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis.
Chaurasia M; Singh PK; Jaiswal AK; Kumar A; Pawar VK; Dube A; Paliwal SK; Chourasia MK
Pharm Res; 2016 Nov; 33(11):2617-29. PubMed ID: 27401407
[TBL] [Abstract][Full Text] [Related]
8. Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.
Gupta S; Dube A; Vyas SP
J Drug Target; 2007 Jul; 15(6):437-44. PubMed ID: 17613662
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis.
Italia JL; Kumar MN; Carter KC
J Biomed Nanotechnol; 2012 Aug; 8(4):695-702. PubMed ID: 22852479
[TBL] [Abstract][Full Text] [Related]
10. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
[TBL] [Abstract][Full Text] [Related]
11. Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.
Murray HW
Future Microbiol; 2010 Sep; 5(9):1301-3. PubMed ID: 20860475
[No Abstract] [Full Text] [Related]
12. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
Wasan KM; Wasan EK; Gershkovich P; Zhu X; Tidwell RR; Werbovetz KA; Clement JG; Thornton SJ
J Infect Dis; 2009 Aug; 200(3):357-60. PubMed ID: 19545212
[TBL] [Abstract][Full Text] [Related]
13. Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.
Berman JD; Ksionski G; Chapman WL; Waits VB; Hanson WL
Antimicrob Agents Chemother; 1992 Sep; 36(9):1978-80. PubMed ID: 1416890
[TBL] [Abstract][Full Text] [Related]
14. Exploitation of lectinized lipo-polymerosome encapsulated Amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis.
Gupta PK; Asthana S; Jaiswal AK; Kumar V; Verma AK; Shukla P; Dwivedi P; Dube A; Mishra PR
Bioconjug Chem; 2014 Jun; 25(6):1091-102. PubMed ID: 24842628
[TBL] [Abstract][Full Text] [Related]
15. Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.
Khatik R; Dwivedi P; Khare P; Kansal S; Dube A; Mishra PR; Dwivedi AK
Expert Opin Drug Deliv; 2014 May; 11(5):633-46. PubMed ID: 24606222
[TBL] [Abstract][Full Text] [Related]
16. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F
Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469
[TBL] [Abstract][Full Text] [Related]
17. Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis.
Singh PK; Pawar VK; Jaiswal AK; Singh Y; Srikanth CH; Chaurasia M; Bora HK; Raval K; Meher JG; Gayen JR; Dube A; Chourasia MK
Int J Biol Macromol; 2017 Dec; 105(Pt 1):1220-1231. PubMed ID: 28780414
[TBL] [Abstract][Full Text] [Related]
18. Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (AmBisome) against Leishmania donovani in hamsters.
Maes L; Germonprez N; Quirijnen L; Van Puyvelde L; Cos P; Vanden Berghe D
Antimicrob Agents Chemother; 2004 Jun; 48(6):2056-60. PubMed ID: 15155199
[TBL] [Abstract][Full Text] [Related]
19. Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.
Asthana S; Jaiswal AK; Gupta PK; Pawar VK; Dube A; Chourasia MK
Antimicrob Agents Chemother; 2013 Apr; 57(4):1714-22. PubMed ID: 23357762
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
Brogden RN; Goa KL; Coukell AJ
Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
